Skip to main content
letter
. 2010 Apr 27;107(21):E90–E91. doi: 10.1073/pnas.0914903107

Table 1.

Genotype, allele, and haplotype frequencies of rs1533428 and rs12994401 in patients with POAG and control subjects

POAG
SNP Genotype/allele/haplotype Control (n = 191) NTG (n = 213) P value HTG (n = 212) P value
rs1533428 Genotype
TT 30 (15.7) 34 (16.0) 33 (15.6)
CT 84 (44.0) 100 (46.9) 0.79* 92 (43.4) 0.99*
CC 77 (40.3) 79 (37.1) 87 (41.0)
Allele
T 144 (37.7) 168 (39.4) 0.66 158 (37.3) 0.94
C 238 (62.3) 258 (60.6) 266 (62.7)
rs12994401 Genotype
TT 16 (8.4) 26 (12.2) 25 (11.8)
CT 101 (52.9) 95 (44.6) 0.19* 103 (48.6) 0.46*
CC 74 (38.7) 92 (43.2) 84 (39.6)
Allele
T 133 (34.8) 147 (34.5) 0.94 153 (36.1) 0.71
C 249 (65.2) 279 (65.5) 271 (63.9)
rs1533428–rs12994401 Haplotype
C-C 0.41 0.41 0.39
C-T 0.21 0.20 0.96* 0.23 0.84*
T-C 0.24 0.24 0.25
T-T 0.14 0.15 0.13

Data are given as number (percentage) for genotype and allele and as frequency for haplotype.

2 test.

Fisher exact test.

Haplotype frequency was analyzed using expectation maximization algorithm.